| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
prostate cancer associated transcript 1 | 0.575 | 0.615 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
POU class 5 homeobox 1B | 0.670 | 0.346 | 2.9E-04 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | ||||||||
|
cancer susceptibility 8 | 0.670 | 0.462 |
|
group | 0.100 | None | 1.000 | 18 | 5 | 2007 | 2019 | |||||||||
|
SMAD family member 7 | 0.470 | 0.769 | 0.55 |
|
group | 0.410 | None | 1.000 | 17 | 7 | 2007 | 2019 | ||||||||
|
colon cancer associated transcript 2 | 0.621 | 0.615 |
|
group | 0.100 | None | 1.000 | 14 | 3 | 2007 | 2019 | |||||||||
|
colorectal cancer associated 2 | 0.769 | 0.154 | 0.75 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | ||||||||
|
colorectal cancer associated 1 | 0.780 | 0.154 |
|
group | 0.100 | None | 1.000 | 9 | 2 | 2008 | 2019 | |||||||||
|
RTEL1-TNFRSF6B readthrough (NMD candidate) | 0.682 | 0.385 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2009 | 2017 | |||||||||
|
chromosome 5 open reading frame 66 | 0.760 | 0.154 | 5.3E-04 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | ||||||||
|
CCND2 antisense RNA 1 | 0.760 | 0.154 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2013 | 2019 | |||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
group | 0.120 | None | 1.000 | 7 | 12 | 2012 | 2019 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
group | 0.100 | None | 1.000 | 7 | 12 | 2012 | 2019 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
group | 0.100 | None | 1.000 | 7 | 4 | 2009 | 2017 | ||||||||
|
CDKN2B antisense RNA 1 | 0.491 | 0.769 |
|
group | 0.100 | None | 1.000 | 6 | 4 | 2009 | 2017 | |||||||||
|
DNA polymerase delta 3, accessory subunit | 0.631 | 0.462 | 1.00 |
|
group | 0.400 | None | 1.000 | 6 | 3 | 2012 | 2019 | ||||||||
|
vesicle transport through interaction with t-SNAREs 1A | 0.674 | 0.154 | 5.4E-04 |
|
group | 0.400 | None | 1.000 | 6 | 4 | 2011 | 2019 | ||||||||
|
ZMIZ1 antisense RNA 1 | 0.780 | 0.115 |
|
group | 0.100 | None | 1.000 | 6 | 1 | 2014 | 2019 | |||||||||
|
ataxin 2 | 0.482 | 0.808 | 0.85 |
|
group | 0.100 | None | 1.000 | 6 | 2 | 2015 | 2019 | ||||||||
|
rhophilin Rho GTPase binding protein 2 | 0.711 | 0.192 | 1.1E-07 |
|
group | 0.400 | None | 1.000 | 6 | 4 | 2008 | 2019 | ||||||||
|
gremlin 1, DAN family BMP antagonist | 0.508 | 0.808 | 0.47 |
|
group | 0.430 | None | 1.000 | 5 | 3 | 2008 | 2020 | ||||||||
|
LDL receptor related protein 1 | 0.482 | 0.769 | 1.00 |
|
group | 0.480 | None | 1.000 | 5 | 1 | 2011 | 2018 | ||||||||
|
KIT ligand | 0.473 | 0.885 | 0.85 |
|
group | 0.410 | None | 1.000 | 5 | 3 | 2009 | 2013 | ||||||||
|
ATPase plasma membrane Ca2+ transporting 1 | 0.666 | 0.500 | 1.00 |
|
group | 0.700 | None | 0.966 | 5 | 9 | 1999 | 2019 | ||||||||
|
transcription factor 7 like 2 | 0.485 | 0.846 | 1.00 |
|
group | 0.490 | None | 1.000 | 5 | 2 | 2002 | 2019 | ||||||||
|
myelin regulatory factor | 0.584 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 5 | 2 | 2014 | 2019 |